eIF5A2 + eIF5A Antibody
Selleck Chemicals
SKU:F2987-20UL
Couldn't load pickup availability

About the Target
eIF5A2 + eIF5A is a target of interest in many antibody-based workflows. eIF5A (Eukaryotic Initiation Factor 5A) and its isoform eIF5A2 are vital proteins that regulate translation and cell proliferation. Both proteins contain the unique amino acid hypusine, a post-translational modification essential for their activity. eIF5A consists of an N-terminal domain rich in β-strands and a C-terminal domain containing a three-turn α-helix. eIF5A2 shares approximately 84% sequence identity with eIF5A1 but exhibits distinct tissue-specific expression patterns. eIF5A plays a key role in stimulating ribosomal peptidyltransferase activity, which aids in the initiation and elongation phases of protein synthesis. eIF5A2 acts as an oncogenic factor in promoting cell growth. Depending on the literature source, eIF5A2 + eIF5A may also be discussed as eIF5A2 + eIF5A.
Reported cellular context includes cytoplasm, endoplasmic reticulum, membrane, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following eIF5A2 + eIF5A across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.
Research Context
eIF5A2 + eIF5A is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, endoplasmic reticulum, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.
Consider these angles when interpreting target-level changes:
- apparent redistribution between cytoplasm, endoplasmic reticulum, and membrane across matched conditions
- changes associated with proliferative state, oncogenic signaling, or treatment response
- co-patterning with orthogonal markers and control conditions that clarify pathway state
- time-matched comparisons so changes reflect biology rather than handling or sampling drift
Variant Considerations
If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for eIF5A2 + eIF5A. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.
Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in eIF5A2 + eIF5A reflect biology rather than handling. When interpreting eIF5A2 + eIF5A, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.
For multi-run studies, a shared reference condition can keep eIF5A2 + eIF5A trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.
- Targets:
- EIF5A2 • EIF5A
- Research Area:
- Cancer
- Application:
- IF • IHC • WB
- Reactivity:
- Human • Mouse • Rat
- Specificity:
- eIF5A2 + eIF5A Antibody [E10C3] recognizes endogenous levels of total eIF5A2 and eIF5A protein.
- Host:
- Rabbit
- Clonality:
- Monoclonal
- Clone:
- E10C3
- Storage Buffer:
- PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.